By Matthew Perrone

U.S. health regulators pledged again Thursday to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers.

The Food and Drug Administration has attempted several times to get rid of menthol but faced pushback from Big Tobacco, members of Congress and competing political interests in both the Obama and Trump administrations. Any menthol ban will take years to implement and will likely face legal challenges from tobacco companies.

Thursday’s announcement is the result of a lawsuit filed by anti-smoking and medical groups last summer to force the FDA to finally make a decision on menthol, alleging that regulators had “unreasonably delayed” responding to a 2013 petition seeking to ban the flavor.

The deadline for the agency’s response was Thursday. The FDA said it aims to propose regulations banning the flavor in the coming year.

The action would also ban menthol and fruity flavors from low-cost, small cigars, which are increasingly popular with young people, especially Black teens.

“We will save save hundreds of thousands of lives and prevent future generations from becoming addicted smokers,” said Dr. Janet Woodcock, the FDA's acting commissioner.

She cited research estimates that banning menthol would prevent 630,000 tobacco-related deaths over 40 years, more than a third of them among African Americans.

Menthol is the only cigarette flavor that was not banned under the 2009 law that gave the FDA authority over tobacco products, an exemption negotiated by industry lobbyists. The act did, though, instruct the agency to continue to weigh banning menthol.

The flavor’s persistence has infuriated anti-smoking advocates, who point to research that menthol’s numbing effect masks the harshness of smoking, likely making it easier to start and harder to quit.

The mint-flavored cigarettes are overwhelmingly used by young people and minorities, particularly Black smokers, 85% of whom smoke menthols. That compares to about a third of white smokers.

“The science is there, the data is there, so why are these products still on the market?” said Carol McGruder of the African American Tobacco Control Leadership Council.

Her group sued along with Action on Smoking and Health, the American Medical Association and the National Medical Association, which represents Black physicians.

For decades, companies focused menthol marketing and promotions on Black communities, including sponsoring music festivals and neighborhood events. Company documents released via 1990s litigation also show companies viewed menthol cigarettes as good “starter” products because they were more palatable for teenagers .

“There was a specific, intentional focus on creating the next generation of smokers by making menthol cigarettes available in those communities,” said Dr. Nia Heard-Garris, who chairs the American Academy of Pediatrics’ group on minority health and equity.

Share:
More In Business
S&P Closes at Record Despite Spread of Omicron Variant
The S&P closed at a record at the major markets ended Thursday's session higher for a third straight day. Adam Coons, Portfolio Manager at Winthrop Capital Management, joins Cheddar News' Closing Bell, where he discusses what has investors feeling jolly before Christmas, and gifts investors with winning buying opportunities entering 2022.
Tips for Traveling Safely Over Holidays as Omicron Variant Spreads
Jeanenne Tornatore, travel expert, media personality, content creator, and former Orbitz senior editor, joins Cheddar News' Closing Bell, where she runs through items flyers should be mindful of this holiday season as the omicron coronavirus variant continues to spread.
Holiday Shopping Challenges During Omicron Rise
With only two days left until Christmas, last-minute shoppers are facing major issues caused by supply chain shortages and the rising omicron variant. Kristen Gall, president of Rakuten Rewards, joins Cheddar News to discuss.
EV Expert Makes the Case for Domestic Mining for Lithium for Batteries
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Indi EV Head of Design on Launching Indi One Smart Car
California-based startup Indi EV is gearing up to release its first crossover vehicle incorporating a supercomputer that will allow, among other things, gaming. Andre Hudson, head of design at Indi EV, joined Cheddar to talk about the launch of the Indi One and how the company is distinguishing itself from leaders in the EV space like Tesla. He also talked about the tech behind the Indi One and noted that the car's computer system will enable people to run applications and even create their own. "As a company, we fundamentally saw a major disconnect between how people transition into their cars using the digital devices in their life," Hudson said
12 Terms of 2021: Web3
Cheddar is looking back at the 12 biggest buzzwords of the year leading up to Christmas. The term for Day 12 is Web3. Definition: (noun) Also known as Web 3.0, a version of the internet where data is decentralized and based on peer-to-peer technologies.
Maker of First FDA-Approved Portable MRI Machine Hyperfine Goes Public
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Load More